Barbara Emde, based in Germany, is currently a Director, Head of General Toxicology (Dept. Nonclinical Drug Safety) at Boehringer Ingelheim, bringing experience from previous roles at Boehringer Ingelheim, Merck KGaA, Darmstadt, Germany and Merck Gruppe. Barbara Emde holds a 2003 - 2023 Diplomate of the American Board of Toxicology in Toxicology @ American Board of Toxicology. With a robust skill set that includes Lifesciences, Histopathology, Biotechnology, Pharmaceutical Industry, Oncology and more, Barbara Emde contributes valuable insights to the industry. Barbara Emde has 2 emails on RocketReach.